AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹3,009 Cr | ₹3,266 Cr | ₹2,739 Cr | ₹4,496 Cr | ₹2,938 Cr |
What is the latest Capital Work in Progress ratio of AUROBINDO PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹3,009 Cr |
| Mar2025 | ₹3,266 Cr |
| Mar2024 | ₹2,739 Cr |
| Mar2023 | ₹4,496 Cr |
| Mar2022 | ₹2,938 Cr |
How is Capital Work in Progress of AUROBINDO PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,009 Cr | -7.87 | |
| Mar2025 | ₹3,266 Cr | 19.22 | |
| Mar2024 | ₹2,739 Cr | -39.08 | |
| Mar2023 | ₹4,496 Cr | 53.07 | |
| Mar2022 | ₹2,938 Cr | - | |
Compare Capital Work in Progress of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹93,560.0 Cr | -2.9% | -5.3% | 42.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,831.0 Cr | -0.4% | -6.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 0.9% | -3.3% | 39.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,355.0 Cr | 0.1% | -7.2% | 28.2% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | -0.3% | -4% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.5% | 3.1% | 0.4% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.9% |
-5.3% |
42.1% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
You may also like the below Video Courses